$PBIO Making CBD Oil Truly Water Soluble. A breakt
Post# of 144503
Pressure BioSciences, Inc. (OTCQB BIO)
Oil based products such as CBD oil are not easily absorbed by the human body. In fact, the human body only absorbs approximately 10% of the CBD ingested when infused in beverages. It has been very difficult for CBD processors to make CBD oil into a water soluble end product that can be fully absorbed by the body. CBD oil processors currently use outdated technology that is inefficient and obsolete. Some CBD processing companies currently make harmful chemical modifications to the CBD oil or use large quantities of chemical detergents to make CBD oil water soluble. These methods have been proven to be ineffective and very costly. These methods do not properly break down the CBD oil resulting in poor quality CBD infused beverages that lack the desired potency being demanded by consumers.
Pressure BioSciences has developed a technological breakthrough that makes CBD oil completely water soluble allowing it to be fully absorbed by the human body when consumed in beverages. The company’s UST Ultra Sheer Technology Platform employs a nanotechnology technique that uses ultra-high pressure to sheer oil droplets to such a small size that they effectively dissolve in water. This patented technology uses no harmful chemicals, is highly cost effective, and creates a far superior quality CBD end product that is far more potent to the body and can be easily infused into a wide variety of infused beverages.
The company has redesigned its UST Technology Platform to be used in the CBD beverage industry. This new technology called the BaroShear K45 has been specifically designed to meet all of the specifications required for the efficient processing of CBD oil into a completely water soluble end product to be used in the CBD infused beverage industry. The BaroShear K45 is a unique and powerful next generation nanoemulsification system that uses the company's UST Ultra Sheer Technology Platform to process CBD oil in a cost effective manner without the use of harmful and expensive chemicals. This scientific breakthrough will be marketed to CBD infused beverage companies and CBD oil processing companies located around the globe. The company already has worldwide sales and distribution channels in place to market and service the BaroShear K45. The company has put collaboration agreements together with several CBD industry veterans leading to strategic partnership opportunities that further benefit the company's research and development efforts. The company's superior CBD end product gives the company a huge branding opportunity that can possibly lead to very substantial contracts and joint venture licensing deals.
The company's BaroShear K45 product launch couldn't have come at a more opportune time in the CBD industry's history. With the passage of the 2018 Farm Bill, entrepreneurs are rushing to grow hemp and extract CBD oil that is water soluble and safe for sale to individual consumers or as an ingredient that is infused into beverages. Projected revenue for CBD infused beverages alone is expected to be $220 million by 2022.
The company recently projected this years revenue to double from $2.5 million to $5 million as a result of the high demand expected for the company's BaroShear K45 technology. Technology companies with 100% growth rates can easily trade at upwards of 10 times annual sales which could realistically lead to a $50 million valuation for the company's stock. With less than 2 million shares outstanding the stock may move significantly higher from current levels in the near term as the current market capitalization is a miniscule $5.9 million offering a substantial upside to the company's shares. Trading at only 1.2 times this years forecasted sales PBIO is a very cheap stock compared with its CBD industry peers. The company previously traded on the NASDAQ for upwards of $18.00. The CBD market is hot and valuations are soaring. PBIO is a great way to add the extraordinary growth of the CBD sector to your portfolio.
http://www.pressurebiosciences.com/
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.